ATRX — Adhera Therapeutics Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Adhera Therapeutics Announces CEO, Senior Management Changes, Plans For Nasdaq Uplist
Brief: Adhera Therapeutics Signs Letter Of Intent With Melior Pharmaceuticals Ii To Acquire A New Class Of Drug For Parkinson’S Disease
Ontario to begin offering second doses of COVID-19 vaccines
Brief: Adhera Therapeutics Inc Determined That Co Would Terminate Its Current Business Operations
Brief: Marina Biotech appoints Isaac Blech to board
Brief: Marina Biotech appoints Amit Shah as chief financial officer
Brief: Marina Biotech announces appointment of Dr. Vuong Trieu as executive chairman
Brief: Marina Biotech provides Q1 2016 financial reports
Brief: Marina Biotech to acquire late-stage program from Turing Pharmaceuticals